Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Song, Jia
BDHRT001, NCT04992377: R-EPOCH in Combination With Ibrutinib for Patients With Classical RT of CLL	Not yet recruiting	2	30	RoW	R-EPOCH in Combination With Ibrutinib	Institute of Hematology & Blood Diseases Hospital, Xian-Janssen Pharmaceutical Ltd.	Richter Transformation	08/24	08/25
Wang, Huipin
NCT05463965: A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines	Completed	3	605	RoW	QM1114-DP, OnabotulinumtoxinA, Placebo	Galderma R&D	Moderate to Severe Glabellar Lines	01/23	06/23